31.5.2017 14:02 | Business Wire
Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.
Chiltern , a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.
With staff based in Japan, Korea and Southeast Asia, IDA has extensive expertise in establishing regulatory and development pathways for Japan and implementing Pan Asian clinical trials to achieve both Japanese and global regulatory objectives. IDA’s experience in a broad range of therapeutic areas and its local knowledge and relationships will allow Chiltern to offer optimal approaches for integrating Japan and Asia into global drug development. In addition, the acquisition opens opportunities for Japanese companies to enter a wider market by relying on Chiltern’s global expertise and connections.
“The acquisition of IDA is driven by our commitment to establish a substantial presence in all major global markets and support our clients with clinical development capabilities worldwide,” said Jim Esinhart, Ph.D. , Chiltern CEO. “Japan and Southeast Asia are among the world’s largest and fastest-growing pharmaceutical markets. IDA will enable us to grow in the APAC region through well-established relationships and local expertise and knowledge.”
IDA will do business as a wholly owned subsidiary of Chiltern and be renamed IDA, a Chiltern Company. As a part of this agreement, IDA’s founder and CEO, John Winebarger , will continue to lead IDA. Winebarger has more than 30 years’ experience working in Japan and will join Chiltern’s leadership team.
To learn more about Chiltern’s global clinical development services, visit Chiltern.com .
Chiltern, a global contract research organization, is a leading provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,300, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You® .
SCORR Marketing for Chiltern
Lea Studer, +1-308-237-5567
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
AZ-PACSCI-EMC23.6.2017 06:43 | pressemeddelelse
PacSci EMC Completes Successful Launch of Company-Owned Demonstrator Satellite
NV-RIMINI-STREET22.6.2017 20:07 | pressemeddelelse
Survey Finds Majority of SAP Licensees Plan to Continue Running Their Proven ERP Release and Are Not Committed to Moving to S/4HANA
AL-CONFEDERATE-MOTORS22.6.2017 19:57 | pressemeddelelse
Confederate Fighter Creates Mayhem As Cool Motorcycle Punk, Mohawk, In Transformers: The Last Knight
VA-CTA22.6.2017 18:00 | pressemeddelelse
CES Unveiled Paris Returns for a Fifth Edition this October
UNITED-ENGINE-CORPORATIO22.6.2017 16:36 | pressemeddelelse
UEC Shows Latest Russian Civil Aero Engines at Paris Air Show
VA-LEARNING-TREE22.6.2017 16:19 | pressemeddelelse
Learning Tree Releases 46 Microsoft Courses for On-Demand Delivery
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum